Explore All Access
Check if your research matches the topics covered in Cancers?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Cancers : Impact Factor & More
eISSN: 2072-6694pISSN: 2072-6694
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Cancers Key Metrics
CiteScore 
5.8
Impact Factor
5 - 10
Scite Index
0.90 5-Year SI
SNIP
1.27
Time to Publish
View Chart Mo
Topics Covered on Cancers
Cancer
Extracellular matrix
Overall survival
Carcinogenesis
Lung cancer
Lymphoma
Neuroendocrine tumors
Extracellular vesicles
Nuclear magnetic resonance
Meningioma
Toxicity
Immunotherapy
Progression-free survival
Positron emission tomography
Hepatocellular carcinoma
Breast cancer
Machine learning
Lung
Oxidative stress
Head and neck
Cancers Journal Specifications
| Overview | |
| Publisher | MDPI |
| Language | English |
| Frequency | Semi-monthly |
| Article Processing Charges | CHF 2600 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Time to Publish
% of papers by time taken from submission to publication
0 to 3 months97%
4 to 6 months3%
7 to 9 months0%
Above 9 months0%
Did you find this useful?
Planning to publish in Cancers ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancers
Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study.
- 8 Apr 2024
- Cancers
Correction: Soda et al. Electrochemical Detection of Global DNA Methylation Using Biologically Assembled Polymer Beads. Cancers 2021, 13, 3787.
- 8 Apr 2024
- Cancers
The Exacerbating Effects of the Tumor Necrosis Factor in Cardiovascular Stenosis: Intimal Hyperplasia.
- 8 Apr 2024
- Cancers
Pathological Insights: Enhanced Vision Transformers for the Early Detection of Colorectal Cancer.
- 8 Apr 2024
- Cancers
Performance of Commercial Dermatoscopic Systems That Incorporate Artificial Intelligence for the Identification of Melanoma in General Practice: A Systematic Review.
- 8 Apr 2024
- Cancers
Simultaneous Visualization of Lung Tumor and Intersegmental Plane during Pulmonary Segmentectomy by Intravenous Injection of Indocyanine Green.
- 8 Apr 2024
- Cancers
Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study.
- 8 Apr 2024
- Cancers
Correction: Soda et al. Electrochemical Detection of Global DNA Methylation Using Biologically Assembled Polymer Beads. Cancers 2021, 13, 3787.
- 8 Apr 2024
- Cancers
The Exacerbating Effects of the Tumor Necrosis Factor in Cardiovascular Stenosis: Intimal Hyperplasia.
- 8 Apr 2024
- Cancers
Pathological Insights: Enhanced Vision Transformers for the Early Detection of Colorectal Cancer.
- 8 Apr 2024
- Cancers
Performance of Commercial Dermatoscopic Systems That Incorporate Artificial Intelligence for the Identification of Melanoma in General Practice: A Systematic Review.
- 8 Apr 2024
- Cancers
Simultaneous Visualization of Lung Tumor and Intersegmental Plane during Pulmonary Segmentectomy by Intravenous Injection of Indocyanine Green.
- 8 Apr 2024
- Cancers
Compare Similar Journals with Cancers
Select Journals to Compare with Cancers
Total journals - 10
You can select up to 3 Journals at a time
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Oncotarget
Publisher: Impact Journals
Annals of Oncology
Publisher: ELSEVIER
BMC Cancer
Publisher: BMC
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
International Journal of Molecular Sciences
Publisher: MDPI
Scientific Reports
Publisher: NATURE PORTFOLIO
Oncology Letters
Publisher: SPANDIDOS PUBL LTD
0 Journals Selected to compare with
Cancers
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Cancers
How long has Cancers been actively publishing? 
Cancers has been in operation since 2009 till date.
What is the publishing frequency of Cancers?
Cancers published with a Semi-monthly frequency.
How many articles did Cancers publish last year?
In 2023, Cancers publsihed 4525 articles.
What is the eISSN & pISSN for Cancers?
For Cancers, eISSN is 2072-6694 and pISSN is 2072-6694.
What is Citescore for Cancers?
Citescore for Cancers is 5.8.
What is SNIP score for Cancers?
SNIP score for Cancers is 1.27.
Who is the publisher of Cancers?
MDPI is the publisher of Cancers.
Your document is 100% secure & confidential 
